ICON Public Limited Company
General ticker "ICLR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $21.1B (TTM average)
ICON Public Limited Company does not follow the US Stock Market performance with the rate: -5.7%.
Estimated limits based on current volatility of 2.7%: low 142.15$, high 149.96$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [135.10$, 236.83$]
- 2025-12-31 to 2026-12-31 estimated range: [117.56$, 207.52$]
Financial Metrics affecting the ICLR estimates:
- Positive: Non-GAAP EPS, $ of 14.00 > 2.19
- Negative: Industry operating cash flow per share per price (median), % of 0.98 <= 2.82
- Positive: 43.26 < Shareholder equity ratio, % of 56.42 <= 63.75
- Negative: Interest expense per share, $ of 2.88 > 0.67
- Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 4.48
- Negative: Inventory ratio change, % of 16.93 > 1.05
- Negative: Investing cash flow per share, $ of -3.23 <= -3.20
- Positive: 8.37 < Operating profit margin, % of 13.26
- Positive: 7.09 < Operating cash flow per share per price, % of 7.39
Short-term ICLR quotes
Long-term ICLR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7,741.39MM | $8,120.18MM | $8,281.68MM |
| Operating Expenses | $6,946.15MM | $7,164.02MM | $7,183.86MM |
| Operating Income | $795.24MM | $956.15MM | $1,097.81MM |
| Non-Operating Income | $-227.39MM | $-331.69MM | $-228.63MM |
| Interest Expense | $229.73MM | $336.70MM | $237.24MM |
| Income(Loss) | $567.85MM | $624.47MM | $869.18MM |
| Taxes | $59.41MM | $11.75MM | $77.71MM |
| Profit(Loss)* | $505.30MM | $612.34MM | $791.47MM |
| Stockholders Equity | $8,497.96MM | $9,240.74MM | $9,523.00MM |
| Inventory | $7.06MM | $0.00MM | $0.00MM |
| Assets | $17,185.28MM | $16,989.86MM | $16,877.68MM |
| Operating Cash Flow | $563.32MM | $1,161.03MM | $1,286.65MM |
| Capital expenditure | $142.16MM | $140.69MM | $168.06MM |
| Investing Cash Flow | $-145.87MM | $-226.65MM | $-266.79MM |
| Financing Cash Flow | $-864.17MM | $-844.04MM | $-837.18MM |
| Earnings Per Share** | $6.20 | $7.46 | $9.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.